On episode #18 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the previous two weeks, 12/9/22 – 12/21/22.
Hosts: Daniel Griffin and Sara Dong
Click arrow to play
Download Puscast 018 (22 MB .mp3, 37 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of Puscast!
Links for this episode
- Human Rabies in Texas, 2021 (CDC)
- Human rabies despite post-exposure prophylaxis (The Lancet)
- The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread (The Lancet)
- An update on eukaryotic viruses revived from ancient permafrost (bioRx)
- Colistin monotherapy vs combination therapy for carbapenem-resistant organisms (NEJM)
- Outcomes of Ceftriaxone vs antistaphylococcal Penicillins or Cefazolin for definitive therapy of Methicillin-susceptible Staphylococcus aureus bacteremia (OFID)
- Salmonella enteritidis cardiovascular implantable electronic device infection (OFID)
- Evaluation of serotonin syndrome with Linezolid and serotonergic agents at an academic medical center (OFID)
- Preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for Intra-abdominal infections (CID)
- Risk factors and outcomes of invasive aspergillosis in kidney transplant recipients (CID)
- Predictive performance of gram staining of catheter tips for Candida catheter-related bloodstream infections (OFID)
- Integrative genetic manipulation of Plasmodium cynomolgireveals multidrug resistance-(JID)
- Clinical characteristics of patients with calcified parenchymal neurocysticercosis and perilesional edema (OFID)
- Impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa (CID)
- Factors contributing to delayed academic advancement of women in infectious diseases (OFID)
- Characterization of problematic alcohol use among physicians (JAMA)
- Alpha-gal syndrome in the ID clinic (OFID)
- Efficacy and safety of Azithromycin vs placebo to treat lower respiratory tract infections associated with low procalcitonin (The Lancet)
Music is by Ronald Jenkees
Leave a Reply